Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 47/100

Termination Rate

16.7%

2 terminated out of 12 trials

Success Rate

80.0%

-6.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

75%

6 of 8 completed with results

Key Signals

6 with results80% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (10)

Trial Status

Completed8
Recruiting2
Terminated2

Trial Success Rate

80.0%

Benchmark: 86.6%

Based on 8 completed trials

Clinical Trials (12)

Research Network

Activity Timeline